India is home to more than 100 million diabetics, and the demand for anti-diabetic drugs is on the rise -- the Rs 20,611 crore anti-diabetic drug market in India is growing at 9 per cent or so.......
Indian pharmaceutical major Cipla has signed up a global supply deal with the $10 billion German drug maker Boehringer Ingelheim.The product development and manufacturing pact, which will be the......
A recent report has suggested that future patent expires in the cardiac and anti-diabetes space would form a good opportunity for smaller firms, given their franchise in these segments. The next......
Pharma major Wockhardt on Wednesday said it has launched Tamsulosin capsules, indicated for problem of prostate enlargement, in the US market on the day one of the expiry of patent covering the......
Despite reservations about 'power and manpower' in India, several large German companies - including BMW,Volkswagen, Bosch, Deutsche Bank and Boehringer - have pledged to invest millions of euros......